Literature DB >> 33641481

Patient-Readiness for Discharge and 30-Day Adherence to Treatment After Coronary Stent Implantation.

Wei Liang1,2, Danni Zuo, Master Candidate1, Tangyihua Li1, Huihua Zhao1.   

Abstract

This study aimed to explore the association between readiness for hospital discharge and 30-day adherence to treatment among patients with coronary heart disease who have undergone coronary stent implantation. A prospective, observational study design was adopted. A total of 153 participants were recruited from five cardiovascular units of a tertiary care teaching hospital in China. Data were collected using the Readiness for Hospital Discharge Scale, Morisky, Green, and Levine Adherence Scale, and Patients' Adherence to Treatment Questionnaire. The results showed that patient-readiness for discharge was high whereas the 30-day adherence to treatment remained suboptimal. Readiness for hospital discharge and medical history of hypertension were significantly associated with patients' 30-day adherence to blood pressure self-monitoring and control (p< .05). This study demonstrates the importance of paying attention to discharge preparation service as it may improve patients' 30-day adherence to treatment after coronary stent implantation.

Entities:  

Keywords:  patient discharge; percutaneous coronary intervention; treatment adherence and compliance

Year:  2021        PMID: 33641481     DOI: 10.1177/1054773821998550

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  2 in total

1.  Factors of Parents-Reported Readiness for Hospital Discharge in Children with Acute Leukemia: A Cross-Sectional Study.

Authors:  Wei Cai; Xiaofen Zheng; Runping Wang; Huifen Zhu; Xinxin Xu; Xiaowen Shen; Chunmei Zhang
Journal:  J Healthc Eng       Date:  2022-04-22       Impact factor: 3.822

2.  Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale.

Authors:  Oriana Awwad; Suha AlMuhaissen; Ayat Al-Nashwan; Salahdein AbuRuz
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.